621 related articles for article (PubMed ID: 35664967)
1. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
3. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
[TBL] [Abstract][Full Text] [Related]
4. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
[TBL] [Abstract][Full Text] [Related]
5.
Ma F; Sun M; Song Y; Wang A; Jiang S; Qian F; Mu G; Tuo Y
Nutrients; 2022 May; 14(9):. PubMed ID: 35565884
[TBL] [Abstract][Full Text] [Related]
6. [Banxia Xiexin Decoction inhibiting colitis-associated colorectal cancer infected with Fusobacterium nucleatum by regulating Wnt/β-catenin pathway].
Jiang YF; Huang YQ; Hu YE; Yang Y; Zheng C; You FM; Zhao ZY
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1266-1274. PubMed ID: 38621974
[TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
8. AC1Q3QWB inhibits colorectal cancer progression by modulating the immune response and balancing the structure of the intestinal microbiota.
Zhu W; Li J; Chen Y; Liu Z; Zhang Q; Kang C
Int Immunopharmacol; 2023 Mar; 116():109768. PubMed ID: 36731153
[TBL] [Abstract][Full Text] [Related]
9.
Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
[TBL] [Abstract][Full Text] [Related]
10. Zerumbone Restores Gut Microbiota Composition in ETBF Colonized AOM/DSS Mice.
Cho HW; Rhee KJ; Eom YB
J Microbiol Biotechnol; 2020 Nov; 30(11):1640-1650. PubMed ID: 32958727
[TBL] [Abstract][Full Text] [Related]
11. Banxia Xiexin Decoction delays colitis-to-cancer transition by inhibiting E-cadherin/β-catenin pathway via Fusobacterium nucleatum FadA.
Jiang Y; Huang Y; Hu Y; Yang Y; You F; Hu Q; Li X; Zhao Z
J Ethnopharmacol; 2024 Jun; 328():117932. PubMed ID: 38382652
[TBL] [Abstract][Full Text] [Related]
12. Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
Ibrahim A; Hugerth LW; Hases L; Saxena A; Seifert M; Thomas Q; Gustafsson JÅ; Engstrand L; Williams C
Int J Cancer; 2019 Jun; 144(12):3086-3098. PubMed ID: 30515752
[TBL] [Abstract][Full Text] [Related]
13. Anchang Yuyang Decoction inhibits experimental colitis-related carcinogenesis by regulating PPAR signaling pathway and affecting metabolic homeostasis of host and microbiota.
Wei X; Liang J; Liu J; Dai Y; Leng X; Cheng Y; Chi L
J Ethnopharmacol; 2024 May; 326():117995. PubMed ID: 38428656
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism.
Lin S; Zhang X; Zhu X; Jiao J; Wu Y; Li Y; Zhao L
J Periodontol; 2023 Mar; 94(3):405-418. PubMed ID: 36088655
[TBL] [Abstract][Full Text] [Related]
15. Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfate.
Suzuki R; Miyamoto S; Yasui Y; Sugie S; Tanaka T
BMC Cancer; 2007 May; 7():84. PubMed ID: 17506908
[TBL] [Abstract][Full Text] [Related]
16. Changes in Gut Microbiome upon Orchiectomy and Testosterone Administration in AOM/DSS-Induced Colon Cancer Mouse Model.
Song CH; Kim N; Nam RH; Choi SI; Jang JY; Lee HN
Cancer Res Treat; 2023 Jan; 55(1):196-218. PubMed ID: 35790194
[TBL] [Abstract][Full Text] [Related]
17. The germ-free mice monocolonization with
Lee YP; Chiu CC; Lin TJ; Hung SW; Huang WC; Chiu CF; Huang YT; Chen YH; Chen TH; Chuang HL
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):207-213. PubMed ID: 30706742
[No Abstract] [Full Text] [Related]
18. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
[TBL] [Abstract][Full Text] [Related]
19. Effects of 17β-estradiol on colorectal cancer development after azoxymethane/dextran sulfate sodium treatment of ovariectomized mice.
Song CH; Kim N; Lee SM; Nam RH; Choi SI; Kang SR; Shin E; Lee DH; Lee HN; Surh YJ
Biochem Pharmacol; 2019 Jun; 164():139-151. PubMed ID: 30981879
[TBL] [Abstract][Full Text] [Related]
20. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
Front Immunol; 2020; 11():588079. PubMed ID: 33072135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]